Clinical trial · Interventional
Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema
Compressive Therapy by Adjustable Compression Garment (Ready Wrap®) in Breast Cancer-related Lymphedema: Randomized Clinical Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a randomized clinical trial, in which the use of an Adjustable compression wrap as a compressive therapy to control the upper limb volume of with lymphedema women secondary to breast cancer will be investigated, in comparison to the use of a compression sleeve conventionally used. It is expected that Adjustable compression wrap will be more effective than standard treatment for the control of lymphedema, in addition to promoting a better quality of life and functionality for women.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Related Lymphedema | — | UNRESOLVED | — |
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Lymphedema of Upper Arm | — | UNRESOLVED | — |
| Lymphedema, Secondary | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Adjustable Compression Wrap | Device | — | UNRESOLVED |
| Compression Sleeve | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Adjustable Compression Wrap
- description
- Daily use of the adjustable compression wrap on the upper limb with breast cancer-related lymphedema during phase 2 of compressive therapy.
- interventionNames
- Device: Adjustable Compression Wrap
- type
- ACTIVE_COMPARATOR
- label
- Compression Sleeve
- description
- Daily use of the compressive sleeve on the upper limb with breast cancer-related lymphedema during phase 2 of compressive therapy
- interventionNames
- Device: Compression Sleeve
Primary outcomes (1)
- measure
- Arm volume
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1\. Women 1. Age over 18 years 2. Undergo surgical treatment for breast cancer 3. Diagnosed with lymphedema in the upper limb stabilized for a period ≥6 months 4. Indicated the second phase of compressive therapy / treatment of lymphedema Exclusion Criteria: 1\. Women with: 1. Bilateral lymphedema; 2. Lymphedema since the preoperative period; 3. Presence of phlogistic signs in the limb with lymphedema; 4. Treatment of lymphedema (phase 1) in the last three months; 5. Previous history of allergic reaction to the material used for compressive therapy; 6. Active regional or remote disease; 7. In chemotherapy or radiation therapy; 8. Functional changes in the upper limbs prior to the diagnosis of breast cancer; 9. Heart disease and decompensated systemic arterial hypertension; psychiatric, mental, neurological disorders or cognitive deficits that make it impossible to answer the questionnaires.
References
Publications (1)
- DERIVEDda Silva JMP, Araujo RDD, da Silva Santos FC, Fabro EAN, de Mello Pinto MV, de Aguiar SS, Thuler LCS, Bergmann A. Complex physical therapy employing self-adjusting garment (ReadyWrap(R)) in breast cancer-related lymphedema cases in Brazilian women: a protocol for a randomized controlled trial. Trials. 2023 Aug 22;24(1):549. doi: 10.1186/s13063-023-07460-4. PMID 37608354